News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Geron Corporation Provides Update on Telomerase Activation Program
July 15, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced that the activities of TA Therapeutics, its joint venture with Hong Kong University of Science and Technology (HKUST), are being fully consolidated into Geron.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Preclinical
Asia
MORE ON THIS TOPIC
Layoff Tracker
Novartis Cuts 550 Employees as Swiss Manufacturing Priorities Shift
November 25, 2025
·
92 min read
·
BioSpace Editorial Staff
Legal
UPDATE: GSK’s Tesaro Sues AnaptysBio Over Current Jemperli Contract; Anaptys Countersues
November 21, 2025
·
3 min read
·
Tristan Manalac
Pipeline
Moderna Cans 3 mRNA Vaccines, Secures $1.5B Loan in Quest for 10% Growth
November 21, 2025
·
2 min read
·
Tristan Manalac
C-suite
Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T
November 20, 2025
·
5 min read
·
Nick Paul Taylor